Paper9744267
p14ARF links the tumour suppressors RB and p53.
Bates S and 6 others. Nature, 1998. Cited by 821 papers, by iCite.
Cite this record
ConductScience Library. p14ARF links the tumour suppressors RB and p53. Papers, record 9744267. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9744267
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carrier Proteins | Major topic |
| DNA-Binding Proteins | Major topic |
| Genes, Tumor Suppressor | Major topic |
| Proteins | Major topic |
| Retinoblastoma Protein | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| Cell Cycle | |
| Cell Cycle Proteins | |
| Cell Transformation, Neoplastic | |
| E2F Transcription Factors | |
| Humans | |
| Models, Biological | |
| Mutation | |
| Retinoblastoma-Binding Protein 1 | |
| Transcription Factor DP1 | |
| Transcription Factors | |
| Tumor Cells, Cultured | |
| Tumor Suppressor Protein p14ARF |
Source PubMed
Cited by332
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 821 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42286666 | Molecular mechanisms and recent advances in cellular senescence. | Cell Biosci | 2026 | https://conductscience.org/library/papers/42286666 | PubMed |
| 41511373 | Distinct Regulation of the ARF and TAp73 Tumor Suppressor Genes by the Transcription Factor E2F1 Enables Discrimination of Cancer Cells from Normal Growing Cells. | Cells | 2026 | https://conductscience.org/library/papers/41511373 | PubMed |
| 41439972 | Utility of Tumor Suppressor E2F Target Gene Promoter Elements to Drive Gene Expression Specifically in Cancer Cells. | Cells | 2025 | https://conductscience.org/library/papers/41439972 | PubMed |
| 40869977 | The Transcriptional Coactivator DEAD/H Box 5 (DDX5) Gene Is a Target of the Transcription Factor E2F1 Deregulated from the Tumor Suppressor pRB. | Genes (Basel) | 2025 | https://conductscience.org/library/papers/40869977 | PubMed |
| 40765316 | Interpreting the Origins and Functions of Noncoding RNAs From the Ribosomal Genes. | J Cell Physiol | 2025 | https://conductscience.org/library/papers/40765316 | PubMed |
| 39769018 | DEAD/H Box 5 (DDX5) Augments E2F1-Induced Cell Death Independent of the Tumor Suppressor p53. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39769018 | PubMed |
| 39595534 | The N-Terminal Region of the Transcription Factor E2F1 Contains a Novel Transactivation Domain and Recruits General Transcription Factor GTF2H2. | Biomolecules | 2024 | https://conductscience.org/library/papers/39595534 | PubMed |
| 39455281 | Molecular and cellular dynamics of squamous cell carcinomas across tissues. | Genes Dev | 2025 | https://conductscience.org/library/papers/39455281 | PubMed |
| 38612764 | The Construction of a Multi-Gene Risk Model for Colon Cancer Prognosis and Drug Treatments Prediction. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38612764 | PubMed |
| 38485987 | ERK pathway agonism for cancer therapy: evidence, insights, and a target discovery framework. | NPJ Precis Oncol | 2024 | https://conductscience.org/library/papers/38485987 | PubMed |
| 38441530 | PR55α-controlled protein phosphatase 2A inhibits p16 expression and blocks cellular senescence induction by γ-irradiation. | Aging (Albany NY) | 2024 | https://conductscience.org/library/papers/38441530 | PubMed |
| 38132337 | Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression. | Biology (Basel) | 2023 | https://conductscience.org/library/papers/38132337 | PubMed |
| 37963443 | The Pathology according to p53 Pathway. | Pathobiology | 2024 | https://conductscience.org/library/papers/37963443 | PubMed |
| 37950153 | High expression of CDKN2A is associated with poor prognosis in colorectal cancer and may guide PD-1-mediated immunotherapy. | BMC Cancer | 2023 | https://conductscience.org/library/papers/37950153 | PubMed |
| 37685884 | Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo MET Amplification in Patients with Metastatic EGFR-Mutated NSCLC. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37685884 | PubMed |
| 37236196 | CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis. | Cancer Cell | 2023 | https://conductscience.org/library/papers/37236196 | PubMed |
| 36833320 | Deregulated E2F Activity as a Cancer-Cell Specific Therapeutic Tool. | Genes (Basel) | 2023 | https://conductscience.org/library/papers/36833320 | PubMed |
| 36830797 | Gene Therapy with p14/tBID Induces Selective and Synergistic Apoptosis in Mutant Ras and Mutant p53 Cancer Cells In Vitro and In Vivo. | Biomedicines | 2023 | https://conductscience.org/library/papers/36830797 | PubMed |
| 35243242 | The KRAS-G12D mutation induces metabolic vulnerability in B-cell acute lymphoblastic leukemia. | iScience | 2022 | https://conductscience.org/library/papers/35243242 | PubMed |
| 34956884 | miR-616-5p Promotes Invasion and Migration of Bladder Cancer via Downregulating NR2C2 Expression. | Front Oncol | 2021 | https://conductscience.org/library/papers/34956884 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ARID4A | 5926 | PubTator's text mining | https://conductscience.org/library/genes/5926 | NCBI Gene |
| CDKN2A | 1029 | PubTator's text mining | https://conductscience.org/library/genes/1029 | NCBI Gene |
| TFDP1 | 7027 | PubTator's text mining | https://conductscience.org/library/genes/7027 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9744267
GET https://conductscience.org/api/papers/v1/9744267/cited_by?page=2